Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c531b0dce54fb192c75fd1f4f8d473 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40 |
filingDate |
1998-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a30553f3801003efe58c1ad7bff5385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7757c73ccf39205872ddea806a15cacb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d87d51cf1b53e27b4131fbac4fa279 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7f012846bebac19210de0a257b10c02 |
publicationDate |
2003-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
SK-283233-B6 |
titleOfInvention |
Phosphonic acid-substituted benzazepinone-N-acetic acid derivatives, and processes for their preparation, and medicaments containing these compounds |
abstract |
Derivatives of general formula (I) and their physiologically acceptable salts of these derivatives are described. Also described is a process for preparing these derivatives by reacting the starting compound of formula (IV) and phosphonomethylcyclopentanecarboxylic acid derivatives with benzazepine-N-acetic acid derivatives, optionally further esterifying the obtained compound. The drug as active ingredient comprises said derivative together with a pharmaceutical excipient or carrier. This drug inhibits neutral endopeptidase |
priorityDate |
1997-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |